|Last Price$9.17||Day Change (%)0.22%|
|Open Price$9.17||Day Change ($)0.02|
|Day Range9.17–9.17||52-Week Range7.96–9.21|
As of Fri 12/09/2016 | USD
We're placing Barr Pharmaceuticals BRL under review while we evaluate the company's decision, announced Tuesday, to acquire Pliva. Barr is paying $2.2 billion in cash for the Croatia-based generic drug firm. The transaction geographically diversifies Barr's primarily U.S.-based operations, as 78% ...
Plus, a top executive bolts from eBay, Brazilian telcos get cheap, and more.
Nick Kaiser's Amana funds, which invest according to Islamic law, are trouncing their large-cap competition.